Technology diffusion and diagnostic testing for prostate cancer

Journal of Urology

Volumn 190, Issue 5, 2013, Pages 1715-1720

  Schroeck, Florian R ^a   Kaufman, Samuel R ^a   Jacobs, Bruce L ^a   Skolarus, Ted A ^a,b   Miller, David C ^a   Weizer, Alon Z ^a   Montgomery, Jeffrey S ^a   Wei, John T ^a   Shahinian, Vahakn B ^a   Hollenbeck, Brent K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Biomedical technology; Intensity modulated; Prostate; Prostate specific antigen; Prostatic neoplasms; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER REGISTRY; COHORT ANALYSIS; COMORBIDITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; MEDICARE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RETROSPECTIVE STUDY; ROBOTICS; STATISTICAL SIGNIFICANCE;

EID: 84888638148     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.05.007     Document Type: Article

References (28)

1. American Cancer Society: Cancer Facts & Figures 2013. Available at http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/ cancer-facts-figures-2013. Accessed March 18, 2013.
2. Mariotto AB, Yabroff KR, Shao Y et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103: 117.
3. Taylor KL, Luta G, Miller AB et al: Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol 2012; 30: 2768.
4. Patel HRH, Linares A and Joseph JV: Robotic and laparoscopic surgery: cost and training. Surg Oncol 2009; 18: 242.
5. Joseph JV, Leonhardt A and Patel HRH: The cost of radical prostatectomy: retrospective comparison of open, laparoscopic, and robot-assisted approaches. J Robotic Surg 2008; 2: 21.
6. Pollack A: Hospitals Look to Nuclear Tool to Fight Cancer. The New York Times, December 26, 2007. Available at http://www.nytimes.com/2007/12/26/ business/26proton.html?scp=2&sq= nuclear+tool&st=nyt. Accessed September 12, 2011.
7. Jacobs BL, Zhang Y, Skolarus TA et al: Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood) 2012; 31: 750.
8. Zietman A, Goitein M and Tepper JE: Technology evolution: is it survival of the fittest? J. Clin Oncol 2010; 28: 4275.
9. Makarov DV, Yu JB, Desai RA et al: The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care 2011; 49: 333.
10. Neuner JM, See WA, Pezzin LE et al: The association of robotic surgical technology and hospital prostatectomy volumes. Cancer 2012; 118: 371.
11. Stitzenberg KB, Wong Y, Nielsen ME et al: Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer 2012; 118: 54.
12. Alkhateeb S and Lawrentschuk N: Consumerism and its impact on robotic-assisted radical prostatectomy. BJU Int 2011; 108: 1874.
13. Steinberg PL and Ghavamian R: Searching robotic prostatectomy online: what information is available? Urology 2011; 77: 941.
14. Richstone L and Kavoussi LR: Barriers to the diffusion of advanced surgical techniques. Cancer 2008; 112: 1646.
15. The Dartmouth Institute for Health Policy and Clinical Practice: The Dartmouth Atlas of Health Care. Available at http://www.dartmouthatlas. org/tools/glossary.aspx. Accessed April 7, 2012.
16. Hu JC, Gu X, Lipsitz SR et al: Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009; 302: 1557.
17. Pollack CE, Weissman G, Bekelman J et al: Physician social networks and variation in prostate cancer treatment in three cities. Health Serv Res 2012; 47: 380.
18. United States Census Bureau: ZIP Code- Tabulation Areas. Available at http://www.census. gov/geo/ZCTA/zcta.html. Accessed February 6, 2009.
19. Etzioni R, Berry KM, Legler JM et al: Prostatespecific antigen testing in black and white men: an analysis of Medicare claims from 1991-1998. Urology 2002; 59: 251.
20. Welch HG, Fisher ES, Gottlieb DJ et al: Detection of prostate cancer via biopsy in the Medicare- SEER population during the PSA era. J Natl Cancer Inst 2007; 99: 1395.
21. Klabunde CN, Potosky AL, Legler JM et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53: 1258.
22. Rabe-Hesketh S and Skrondal A: Multilevel and Longitudinal Modeling Using Stata, 2nd ed. College Station, Texas: Stata Press 2008.
23. Diez Roux AV, Merkin SS, Arnett D et al: Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 2001; 345: 99.
24. Drazer MW, Huo D, Schonberg MA et al: Population- based patterns and predictors of prostatespecific antigen screening among older men in the United States. J Clin Oncol 2011; 29: 1736.
25. Howlader N, Noone AM, Krapcho M et al: SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda: National Cancer Institute 2012. Available at http://seer. cancer.gov/csr/1975-2009-pops09. Accessed November 27, 2012.
26. Axelrod DA, McCullough KP, Brewer ED et al: Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation. Am J Transplant 2010; 10: 987.
27. Brada M, Pijls-Johannesma M and De Ruysscher D: Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 2007; 25: 965.
28. Schade GR, Keller J, Ives K et al: Histotripsy focal ablation of implanted prostate tumor in an ACE-1 canine cancer model. J Urol 2012; 188: 1957.